Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Pegylated liposomal doxorubicin|DRUG: Carboplatin|DRUG: trastuzumab
Sponsor: US Oncology Research
Collaborators: Ortho Biotech, Inc.|Tibotec Pharmaceutical Limited